Congratulations to Dr. Matthew Macauley on receiving the 2026 Horace S. Isbell Award
Tag: GlycoNet
Sugar-based vaccine against bacterial diarrhea shows promise in Phase 1 trial
A step closer to a vaccine for Campylobacter jejuni, a major global cause of
diarrheal illness.
32nd International Carbohydrate Symposium
GlycoNet will be attending the 32nd International Carbohydrate Symposium (ICS 2026), taking place July 5–9, 2026, in Bratislava, Slovakia.
GlycoNet community member honoured with Roy L. Whistler International Award in Carbohydrate Chemistry
Congratulations to Dr. Todd Lowary on this recognition from the International Carbohydrate Organization.
AdvanCell and GlycoNet-supported startup 48Hour Discovery announce collaboration and exclusive licensing agreement
48Hour Discovery partners with AdvanCell to advance a peptide-based Lead-212 radioligand therapy program for oncology.
Balloon-like particles help reveal hidden sugar signals in the immune system
GlycoNet researchers have tailored liposome probes to detect molecular cues often missed by standard tools, offering a clearer picture of how immune cells communicate.
Announcing the 2026 GlycoNet Trainee Association Executive Committee
The committee will support GlycoNet trainees in advancing their skills and knowledge through professional development activities.
GlycoNet Investigator receives 2025 Innovation Award
Congratulations to Dr. Matthew Macauley on being recognized at the 2025 University of Alberta Innovation Awards.
2025 Wrapped at GlycoNet
A look back at this year’s highlights from the GlycoNet community, from growing partnerships to breakthroughs in glycomics—the study of complex sugar molecules.
New machine learning model reveals unexpected protein-sugar interactions
By predicting surprising interactions beyond its training data, the model opens paths to deeper insight into molecular behaviour within complex systems.